New and recently funded Medical Startups
1
Country: Australia | Funding: A$83M
Everlab offers an AI-powered preventative care platform. Its digital app provides patients with a longitudinal view of their health by organising diagnostics, doctors, specialists, prescriptions, and care in one place. It integrates with over 1,850 health provider locations and onboards more than 180 active doctors. It caters to major corporates, including Boston Consulting Group, BHP and Bain & Company.
Everlab offers an AI-powered preventative care platform. Its digital app provides patients with a longitudinal view of their health by organising diagnostics, doctors, specialists, prescriptions, and care in one place. It integrates with over 1,850 health provider locations and onboards more than 180 active doctors. It caters to major corporates, including Boston Consulting Group, BHP and Bain & Company.
2
Country: USA | Funding: $138M
Serapha Bio is a clinical-stage biotechnology company focused on developing a base-editing therapy for Alpha-1 Antitrypsin Deficiency. The company's main asset SERP-01 is being investigated as a potential treatment for alpha-1-antitrypsin deficiency, targets the SERPINA1 E342K mutation. Early clinical data on SERP-01 give hope that this is a potentially best-in-class base editing therapy that can restore AAT to physiologic levels in patients with the most severe form of this disease
Serapha Bio is a clinical-stage biotechnology company focused on developing a base-editing therapy for Alpha-1 Antitrypsin Deficiency. The company's main asset SERP-01 is being investigated as a potential treatment for alpha-1-antitrypsin deficiency, targets the SERPINA1 E342K mutation. Early clinical data on SERP-01 give hope that this is a potentially best-in-class base editing therapy that can restore AAT to physiologic levels in patients with the most severe form of this disease
3
Country: USA | Funding: $217M
Osanni Bio is a biotechnology company developing therapies aimed at preventing and reversing blindness caused by retinal diseases.
Osanni Bio is a biotechnology company developing therapies aimed at preventing and reversing blindness caused by retinal diseases.
4
Country: USA | Funding: $59M
xCures is a SaaS platform that aggregates, organizes and structures EMRs providing multimodal data across all diseases.
xCures is a SaaS platform that aggregates, organizes and structures EMRs providing multimodal data across all diseases.
5
Country: USA | Funding: $117.5M
Trase develops medical agentic AI operating system that enables the creation of purpose-built AI agents, including those focused on patient access and navigation, clinical research, resource optimization, clinician support, care pathway automation, care management and revenue cycle management. The company touts that organizations can utilize its agents without moving their data or compromising control.
Trase develops medical agentic AI operating system that enables the creation of purpose-built AI agents, including those focused on patient access and navigation, clinical research, resource optimization, clinician support, care pathway automation, care management and revenue cycle management. The company touts that organizations can utilize its agents without moving their data or compromising control.
6
Country: USA | Funding: $335M
Its gout drug Dotinurad is a once-daily oral inhibitor of urate transporter 1, designed to help the kidneys excrete uric acid. Excess uric acid can lead to the formation of crystals in the joints, causing the painful inflammation associated with gout. The drug's molecule is already approved in several Asian markets.
Its gout drug Dotinurad is a once-daily oral inhibitor of urate transporter 1, designed to help the kidneys excrete uric acid. Excess uric acid can lead to the formation of crystals in the joints, causing the painful inflammation associated with gout. The drug's molecule is already approved in several Asian markets.
7
Country: UK
BetterSpace aim to transform the volume of activity taken for mental wellbeing, covering both prevention and recovery.
BetterSpace aim to transform the volume of activity taken for mental wellbeing, covering both prevention and recovery.
8
Country: USA | Funding: $463M
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
9
Country: USA | Funding: $115K
The New England Medical Innovation Center is a nonprofit that provides expert education, connections to funding, and specialized expertise to innovators and entrepreneurs in the medical technologies space.
The New England Medical Innovation Center is a nonprofit that provides expert education, connections to funding, and specialized expertise to innovators and entrepreneurs in the medical technologies space.
10
Country: Israel | Funding: $225.6M
Augmedics develops cutting-edge technologies for future surgery. Augmedics develops a smart surgical system - The ViZOR: An Augmented Reality Head Mounted Display equipped with various sensors and machine learning capabilities, to be the enabling technology for future surgery.
Augmedics develops cutting-edge technologies for future surgery. Augmedics develops a smart surgical system - The ViZOR: An Augmented Reality Head Mounted Display equipped with various sensors and machine learning capabilities, to be the enabling technology for future surgery.
